Diprophylline
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Saliva: a Reliable Sample Matrix in Bioanalytics
- Inserto Inglés
- Methylxanthines Induce Structural and Functional Alterations of the Cardiac
- (12) United States Patent (10) Patent No.: US 9.446,137 B2 Magome Et Al
- Pharmacology and Toxicology
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- 1. X-R, O N 1999;63:1-38
- Pharmacology
- (12) Patent Application Publication (10) Pub. No.: US 2012/0329780 A1 Thormann Et Al
- Diprophylline Inhibits Non‑Small Cell Lung Cancer A549 Cell Proliferation and Migration, and Promotes Apoptosis, by Downregulating PI3K Signaling Pathway
- 2015 Report on Prohibited Substances
- Administered by Inhalation Inasthma
- (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Two Fatal Cases of Caffeine Poisoning
- (12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
- DIPHYLLIN Suppositories Composition Diphyllin Children Suppositories Each Suppository Contains Diprophylline 150 Mg